Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 69676 - 69700 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	C2CD4B	388125	upregulated	Silicon Dioxide analog results in increased expression of C2CD4B mRNA	15q22.2	A24194
Silicon dioxide	Approved	C2CD5	9847	downregulated	Silicon Dioxide results in decreased expression of C2CD5 mRNA	12p12.1	A24196
Silicon dioxide	Approved	C3	718	downregulated	Silicon Dioxide analog results in decreased expression of C3 mRNA	19p13.3	A24195
Silicon dioxide	Approved	C3AR1	719	downregulated	Silicon Dioxide analog results in decreased expression of C3AR1 mRNA	12p13.31	A24195
Silicon dioxide	Approved	C4BPA	722	downregulated	Silicon Dioxide analog results in decreased expression of C4BPA mRNA	1q32.2	A24195
Silicon dioxide	Approved	C4BPB	725	upregulated	Silicon Dioxide analog results in increased expression of C4BPB mRNA	1q32.1	A24195
Silicon dioxide	Approved	C5	727	downregulated	Silicon Dioxide analog results in decreased expression of C5 mRNA	9q33.2	A24195
Silicon dioxide	Approved	C5	727	downregulated	Silicon Dioxide results in decreased expression of C5 mRNA	9q33.2	A24196
Silicon dioxide	Approved	C5AR1	728	downregulated	Silicon Dioxide analog results in decreased expression of C5AR1 mRNA	19q13.32	A24195
Silicon dioxide	Approved	C5AR1	728	downregulated	Silicon Dioxide results in decreased expression of C5AR1 mRNA	19q13.32	A24196
Silicon dioxide	Approved	C6	729	downregulated	Silicon Dioxide analog results in decreased expression of C6 mRNA	5p13.1	A24195
Silicon dioxide	Approved	C7	730	upregulated	Silicon Dioxide analog results in increased expression of C7 mRNA	5p13.1	A24195
Silicon dioxide	Approved	CA11	770	downregulated	Silicon Dioxide analog results in decreased expression of CA11 mRNA	19q13.33	A24195
Silicon dioxide	Approved	CA12	771	downregulated	Silicon Dioxide analog results in decreased expression of CA12 mRNA	15q22.2	A24195
Silicon dioxide	Approved	CA13	377677	downregulated	Silicon Dioxide analog results in decreased expression of CA13 mRNA	8q21.2	A24195
Silicon dioxide	Approved	CA2	760	downregulated	Silicon Dioxide analog results in decreased expression of CA2 mRNA	8q21.2	A24195
Silicon dioxide	Approved	CA2	760	upregulated	Silicon Dioxide analog results in increased expression of CA2 mRNA	8q21.2	A24194
Silicon dioxide	Approved	CA3	761	upregulated	Silicon Dioxide analog results in increased expression of CA3 mRNA	8q21.2	A24194
Silicon dioxide	Approved	CA5B	11238	upregulated	Silicon Dioxide analog results in increased expression of CA5B mRNA	Xp22.2	A24194
Silicon dioxide	Approved	CA8	767	upregulated	Silicon Dioxide analog results in increased expression of CA8 mRNA	8q12.1	A24194 A24195
Silicon dioxide	Approved	CA9	768	downregulated	Silicon Dioxide analog results in decreased expression of CA9 mRNA	9p13.3	A24195
Silicon dioxide	Approved	CA9	768	upregulated	Silicon Dioxide results in increased expression of CA9 mRNA	9p13.3	A24196
Silicon dioxide	Approved	CABLES1	91768	upregulated	Silicon Dioxide analog results in increased expression of CABLES1 mRNA	18q11.2	A24195
Silicon dioxide	Approved	CABP1	9478	downregulated	Silicon Dioxide analog results in decreased expression of CABP1 mRNA	12q24.31	A24195
Silicon dioxide	Approved	CABYR	26256	upregulated	Silicon Dioxide results in increased expression of CABYR mRNA	18q11.2	A24197 A24196

Displaying entries 69676 - 69700 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability